About Citro Pharma
Citro Pharma is a company based in Guelph (Canada) by Kanti Mapara. It operates as a B2B and Export. Citro Pharma offers products and services including Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and Vaccines. Citro Pharma operates in a competitive market with competitors including Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Intravacc, among others.
- Headquarter Guelph, Canada
- Founders Kanti Mapara
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Citro Pharma Private Limited
- Date of Incorporation 14 Oct, 2016
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$1.52 M (USD)-26.52as on Mar 31, 2023
-
Net Profit
$61.23 K (USD)-61.76as on Mar 31, 2023
-
EBITDA
-$24.11 K (USD)-111.13as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Citro Pharma
Citro Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and Vaccines.
Solid form medications for various treatments and diseases.
Generic versions of injectable drugs for medical use.
Drugs targeting cancer therapy and related conditions.
Biological products similar to reference drugs.
Vaccines for disease prevention and immunization.
Products like human albumin for blood-related treatments.
Funding Insights of Citro Pharma
Detailed funding history for Citro Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Citro Pharma
Investment portfolio details for Citro Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Citro Pharma
Detailed financials for Citro Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Citro Pharma Comparisons
Peer comparison for Citro Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Citro Pharma
Citro Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Intravacc, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| Locked | Locked | Locked |
Contract manufacturing of bio-therapeutics and vaccines is provided.
|
|
| Locked | Locked | Locked |
Vaccine development services for bacterial and viral vaccines are provided.
|
|
| Locked | Locked | Locked |
New molecules are discovered, developed, and manufactured in biotechnology.
|
Detailed competitors of Citro Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Citro Pharma
Complete news archive for Citro Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Citro Pharma
Citro Pharma is headquartered in Guelph, Canada. It is registered at Guelph, Ontario, Canada.
Annual revenue of Citro Pharma is $1.52M as on Mar 31, 2023.
Citro Pharma, based in Canada, specializes in manufacturing and marketing a wide range of high-quality pharmaceutical and biopharmaceutical drugs, including oncology and biosimilars. They export products worldwide, partner with leading manufacturers, and focus on timely delivery and client satisfaction. The company operates in multiple countries, emphasizing affordable healthcare solutions through research and distribution.
Citro Pharma offers Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and 2 more products and services.